Crunching the numbers for TXG... Refresh in a moment for the full analysis.
10x Genomics, Inc. (TXG)
Healthcare
healthy
$23.27
Updated: 2026-04-12
61
TradeApes Score
add
Financial Strength
65
Healthy
Operating Trend
73
Healthy
Valuation
55
Mixed
Capital Allocation
30
Weak
Risk
80
Strong
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.